These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18551629)

  • 1. Peripheral tolerance limits CNS accumulation of CD8 T cells specific for an antigen shared by tumor cells and normal astrocytes.
    Calzascia T; Loh JM; Di Berardino-Besson W; Masson F; Guillaume P; Burkhardt K; Herrera PL; Dietrich PY; Walker PR
    Glia; 2008 Nov; 56(15):1625-36. PubMed ID: 18551629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells.
    Sasaki K; Bean A; Shah S; Schutten E; Huseby PG; Peters B; Shen ZT; Vanguri V; Liggitt D; Huseby ES
    J Immunol; 2014 Apr; 192(7):3029-42. PubMed ID: 24591371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTPN2 restrains CD8⁺ T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice.
    Wiede F; Ziegler A; Zehn D; Tiganis T
    J Autoimmun; 2014 Sep; 53():105-14. PubMed ID: 24997008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of immune tolerance induction through the thymic expression of a peripheral tissue-specific protein.
    Antonia SJ; Geiger T; Miller J; Flavell RA
    Int Immunol; 1995 May; 7(5):715-25. PubMed ID: 7547699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8(+) T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function.
    Ohlén C; Kalos M; Cheng LE; Shur AC; Hong DJ; Carson BD; Kokot NC; Lerner CG; Sather BD; Huseby ES; Greenberg PD
    J Exp Med; 2002 Jun; 195(11):1407-18. PubMed ID: 12045239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous autoimmunity sufficiently potent to induce diabetes mellitus is insufficient to protect against insulinoma.
    Zwicker K; Chatten C; Gratton K; Demetrick D; Serra P; Shameli A; Santamaria P; Bathe OF
    J Immunol; 2009 Aug; 183(3):1705-14. PubMed ID: 19570832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligodendrocytes enforce immune tolerance of the uninfected brain by purging the peripheral repertoire of autoreactive CD8+ T cells.
    Na SY; Hermann A; Sanchez-Ruiz M; Storch A; Deckert M; Hünig T
    Immunity; 2012 Jul; 37(1):134-46. PubMed ID: 22683122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
    Zierden M; Kühnen E; Odenthal M; Dienes HP
    Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive transfer enables tumor rejection targeted against a self-antigen without the induction of autoimmunity.
    Eck SC; Turka LA
    Cancer Res; 2001 Apr; 61(7):3077-83. PubMed ID: 11306490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation.
    Blachère NE; Orange DE; Santomasso BD; Doerner J; Foo PK; Herre M; Fak J; Monette S; Gantman EC; Frank MO; Darnell RB
    Eur J Immunol; 2014 Nov; 44(11):3240-51. PubMed ID: 25103845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination.
    Jackson CM; Kochel CM; Nirschl CJ; Durham NM; Ruzevick J; Alme A; Francica BJ; Elias J; Daniels A; Dubensky TW; Lauer P; Brockstedt DG; Baxi EG; Calabresi PA; Taube JM; Pardo CA; Brem H; Pardoll DM; Lim M; Drake CG
    Clin Cancer Res; 2016 Mar; 22(5):1161-72. PubMed ID: 26490306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocyte-induced regulatory T cells mitigate CNS autoimmunity.
    Trajkovic V; Vuckovic O; Stosic-Grujicic S; Miljkovic D; Popadic D; Markovic M; Bumbasirevic V; Backovic A; Cvetkovic I; Harhaji L; Ramic Z; Mostarica Stojkovic M
    Glia; 2004 Aug; 47(2):168-79. PubMed ID: 15185395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary bladder epithelium antigen induces CD8+ T cell tolerance, activation, and autoimmune response.
    Liu W; Evanoff DP; Chen X; Luo Y
    J Immunol; 2007 Jan; 178(1):539-46. PubMed ID: 17182594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-priming of T cells to intracranial tumor antigens elicits an immune response that fails in the effector phase but can be augmented with local immunotherapy.
    Velicu S; Han Y; Ulasov I; Brown IE; El Andaloussi A; Gajewski TF; Lesniak MS
    J Neuroimmunol; 2006 May; 174(1-2):74-81. PubMed ID: 16504307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The brain parenchyma is permissive for full antitumor CTL effector function, even in the absence of CD4 T cells.
    Walker PR; Calzascia T; Schnuriger V; Scamuffa N; Saas P; de Tribolet N; Dietrich PY
    J Immunol; 2000 Sep; 165(6):3128-35. PubMed ID: 10975826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-presentation of self antigens to CD8+ T cells: the balance between tolerance and autoimmunity.
    Kurts C; Heath WR; Carbone FR; Kosaka H; Miller JF
    Novartis Found Symp; 1998; 215():172-81; discussion 181-90. PubMed ID: 9760579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early immunization induces persistent tumor-infiltrating CD8+ T cells against an immunodominant epitope and promotes lifelong control of pancreatic tumor progression in SV40 tumor antigen transgenic mice.
    Otahal P; Schell TD; Hutchinson SC; Knowles BB; Tevethia SS
    J Immunol; 2006 Sep; 177(5):3089-99. PubMed ID: 16920946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leveraging TCR Affinity in Adoptive Immunotherapy against Shared Tumor/Self-Antigens.
    Miller AM; Bahmanof M; Zehn D; Cohen EEW; Schoenberger SP
    Cancer Immunol Res; 2019 Jan; 7(1):40-49. PubMed ID: 30482746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity.
    Zehn D; Bevan MJ
    Immunity; 2006 Aug; 25(2):261-70. PubMed ID: 16879996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell tolerance and autoimmunity to systemic and tissue-restricted self-antigens.
    Lohr J; Knoechel B; Nagabhushanam V; Abbas AK
    Immunol Rev; 2005 Apr; 204():116-27. PubMed ID: 15790354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.